EUVIMEDEUVIMED entdecken
Crossref

The nanoparticle-mediated delivery of therapeutic siRNA’s targeting fusion genes in leukemia

M Du Plessis, O Heidenreich, I Jeremias

Klinische Pädiatrie · 01.05.2024 · 236 (03) · 203-204

DOI: 10.1055/s-0044-1786569 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Klinische Pädiatrie, erschienen am 01.05.2024. Verfasst von M Du Plessis und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid (AML) and acute lymphoblastic (ALL) leukemias can be characterized by chromosomal rearrangements, resulting in fusion-oncoproteins that can block hematopoietic differentiation and induces aberrant gene expression. Therapeutic siRNAs can effectively target these gene fusions, however effective delivery and siRNA degradation limit their application. Lipid nanoparticles (LNPs) have been reported to safely and effectively deliver siRNAs to target cells. Here, we investigated the delivery of siRNA’s targeting the fusion junctions MLL-AF4 in ALL, and MLL-AF6 in AML cells by utilizing LNP formulations with differences in lipid composition and molar ratios. Furthermore, we assessed the uptake efficacy of LNPs and target gene knockdown. We also investigated the efficacy of LNPs with and without a targeting moiety for the recognition of the VLA-4 receptor on hematopoietic cells. We observed differences in LNP uptake and siRNA-mediated knockdown efficiency between ALL and AML, where AML cells were more responsive to knockdown following LNP treatment. These differences will allow us to optimize LNP formulations to deliver target siRNAs for the treatment of distinct leukemias. Publication History Article published online: 10 May 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Plessis, M. D., Heidenreich, O., & Jeremias, I. (2024). The nanoparticle-mediated delivery of therapeutic siRNA’s targeting fusion genes in leukemia. Klinische Pädiatrie, 236(03), 203-204. https://doi.org/10.1055/s-0044-1786569

Vancouver

Plessis MD, Heidenreich O, Jeremias I. The nanoparticle-mediated delivery of therapeutic siRNA’s targeting fusion genes in leukemia. Klinische Pädiatrie. 2024;236(03):203-204. doi:10.1055/s-0044-1786569

BibTeX
@article{Plessis2024,
  author = {Plessis, M Du and Heidenreich, O and Jeremias, I},
  title = {The nanoparticle-mediated delivery of therapeutic siRNA’s targeting fusion genes in leukemia},
  journal = {Klinische Pädiatrie},
  year = {2024},
  volume = {236},
  number = {03},
  pages = {203--204},
  doi = {10.1055/s-0044-1786569}
}
Kostenlos starten →